Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “rheumatoid arthritis”

Self-Care Education for Joint Stiffness and Functional Ability in Rheumatoid ArthritisNot Yet Recruiting
NCT07761767NAUpdated Aug 13, 2026
Sponsor: Assiut University
Rheumatoid Arthritis (RA)
Oxidative Stress and Cardiovascular Risk in Patients With Rheumatoid ArthritisRecruiting
NCT07760662N/AUpdated Aug 12, 2026
Sponsor: University of La Laguna
Rheumatoid Arthritis (RA · Oxidative Stress · Cardiovascular (CV) Risk
Spain
Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）Recruiting
NCT06801119Phase 1Updated Aug 12, 2026
Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd
Systemic Lupus Erythematosus · Scleroderma · Rheumatoid Arthritis
China
Phase 1b/2 Study of IV Sarilumab in Adult With RARecruiting
NCT07704580Phase 1, Phase 2Updated Aug 11, 2026
Sponsor: Sanofi
Rheumatoid Arthritis
United States
A Study of F8IL10 Intra-articular Treatment in Rheumatoid ArthritisRecruiting
NCT07245992Phase 1Updated Aug 11, 2026
Sponsor: Philogen S.p.A.
Rheumatoid Arthritis (RA)
Italy
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's DiseaseRecruiting
NCT07041099Phase 1Updated Aug 11, 2026
Sponsor: Cullinan Therapeutics Inc.
Sjögren · Sjogren Disease · Sjogren's Syndrome
United States, France, Germany, Italy
A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory ArthritisActive Not Recruiting
NCT05197036N/AUpdated Aug 11, 2026
Sponsor: Smith & Nephew, Inc.
Osteoarthritis · Post-traumatic Arthritis · Rheumatoid Arthritis
United States, Australia, Canada, Netherlands, Sweden
A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)Recruiting
NCT07564154Phase 1Updated Aug 11, 2026
Sponsor: Kali Therapeutics, Inc.
Rheumatoid Arthritis (RA)
Australia, New Zealand
Use of Acthar in Rheumatoid Arthritis (RA) Related FlaresCompleted
NCT02541955Phase 4Updated Aug 11, 2026
Sponsor: Veena Ranganath, MD, MS
Rheumatoid Arthritis (RA)
United States
Biotherapies and Therapeutic Education in Chronic Inflammatory RheumatismCompleted
NCT03838939NAUpdated Aug 10, 2026
Sponsor: University Hospital, Clermont-Ferrand
Rheumatoid Arthritis · Spondyloarthritis
France
Creating Health Course Study for People With Rheumatological Conditions and Mood DisordersRecruiting
NCT07180537NAUpdated Aug 10, 2026
Sponsor: Terry L. Wahls
Rheumatoid Arthritis · Sjogren's Syndrome · Systemic Lupus Erythematosus · Mixed Connective Tissue Disease
United States
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)Recruiting
NCT06977724Phase 1Updated Aug 10, 2026
Sponsor: AbbVie
Dry Eye Syndrome · Systemic Lupus Erythematosus
United States, France, Netherlands
Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot Yet Recruiting
NCT07737470N/AUpdated Aug 10, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
Pericarditis · Tako-TSUBO Cardiomyopathy · Myocarditis · Inflammatory Cardiomyopathies
JAK Inhibitor Dose TAPering Strategy StudyRecruiting
NCT06687551Phase 4Updated Aug 7, 2026
Sponsor: University Hospital, Toulouse
Rheumatoid Arthritis (RA
France
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)Recruiting
NCT06733935Phase 1, Phase 2Updated Aug 7, 2026
Sponsor: Nkarta, Inc.
Systemic Sclerosis · Idiopathic Inflammatory Myopathies · Antineutrophil Cytoplasmic Antibody-Associated Vasculitis · Rheumatoid Arthritis
United States, Australia, Puerto Rico
TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDsNot Yet Recruiting
NCT07748728Phase 2Updated Aug 6, 2026
Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd
Rheumatoid Arthritis (RA)
China
Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid ArthritisRecruiting
NCT07745426Phase 2Updated Aug 4, 2026
Sponsor: Tanta University
Rheumatoid Arthritis (RA)
Egypt
A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male ParticipantsNot Yet Recruiting
NCT07744828Phase 1Updated Aug 4, 2026
Sponsor: Dr. Reddy's Laboratories Limited
Healthy Volunteers
New Zealand
Inflammatory Arthritis and TangoCompleted
NCT03840785NAUpdated Aug 3, 2026
Sponsor: University Hospital, Clermont-Ferrand
Rheumatoid Arthritis (RA) · Spondyloarthritis (SA)
France
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune DiseasesRecruiting
NCT07284797Phase 1Updated Aug 3, 2026
Sponsor: Xencor, Inc.
Healthy · Idiopathic Inflammatory Myopathies · Systemic Sclerosis · Sjögren's Disease
Australia
Korean Post-marketing Surveillance for Xeljanz XRRecruiting
NCT04876781N/AUpdated Aug 3, 2026
Sponsor: Pfizer
Active Moderate to Severe Rheumatoid Arthritis · Active Ankylosing Spondylitis · Active Psoriatic Arthritis
South Korea
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Active Not Recruiting
NCT05869955Phase 1Updated Aug 3, 2026
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Systemic Lupus Erythematosus · Idiopathic Inflammatory Myopathy · Systemic Sclerosis · Rheumatoid Arthritis
United States, Belgium, France, Germany, Italy +1 more
A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid ArthritisRecruiting
NCT07230353Phase 1Updated Aug 3, 2026
Sponsor: Xencor, Inc.
Rheumatoid Arthritis
Georgia, Moldova, New Zealand
Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician-Performed DAS28/CDAI: A Non-Clinical, Non-Interventional, Non-Academic StudyCompleted
NCT07740200N/AUpdated Jul 31, 2026
Sponsor: Synovo Ltd.
Rheumatoid Arthritis (RA)
Pakistan
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Recruiting
NCT06991114Phase 2Updated Jul 31, 2026
Sponsor: Artiva Biotherapeutics, Inc.
Refractory Rheumatoid Arthritis (RA) · Idiopathic Inflammatory Myopathies (IIMs) · Systemic Sclerosis (SSc) · Rheumatoid Arthritis (RA
United States, Brazil, Bulgaria, France, Germany +6 more

Previous page Next page